Invention Grant
- Patent Title: Inhibition of Olig2 activity
-
Application No.: US17367099Application Date: 2021-07-02
-
Publication No.: US11691951B2Publication Date: 2023-07-04
- Inventor: Graham Beaton , Fabio C. Tucci , Satheesh B. Ravula , Stanton F. McHardy , Francisco Xavier Ruiz , Ambrosio Lopez , Bismarck Campos , Hua-Yu Leo Wang
- Applicant: Curtana Pharmaceuticals, Inc.
- Applicant Address: US TX Austin
- Assignee: CURTANA PHARMACEUTICALS, INC.
- Current Assignee: CURTANA PHARMACEUTICALS, INC.
- Current Assignee Address: US TX Austin
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: C07D239/48
- IPC: C07D239/48 ; C07D401/12 ; C07D403/04 ; C07D403/12 ; C07D405/12 ; C07D401/14
Abstract:
Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are methods of using such Olig2 inhibitors, alone and in combination with other compounds, for treating cancer and other diseases. In particular the Olig2 inhibitors may be used to treat glioblastoma.
Public/Granted literature
- US20210347739A1 INHIBITION OF OLIG2 ACTIVITY Public/Granted day:2021-11-11
Information query
